Search Thermo Fisher Scientific
SARS-CoV-2 Molecular and Serological Quality Controls
Advance your SARS-CoV-2 research and clinical results with our comprehensive portfolio of third-party Quality Controls
Validate and monitor the results of your SARS-CoV-2 assays with Thermo Scientific™ molecular and serological controls. Our trusted, independent AcroMetrix™ and MAS™ quality controls offer the following benefits for your testing program.
Assay validation and verification studies
Validate your SARS-CoV-2 test with a third-party control before adopting a new assay.
Assay monitoring
Monitor run-to-run variability by utilizing a single QC lot against multiple lots of reagents.
Compliance with international guidelines
Comply with ISO 15189/2012 which recommends using third-party and independent quality controls.
Research Use Only
Research Use Only
Research Use Only
For In Vitro Diagnostic Use
AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO)
AcroMetrix SARS-CoV-2 Control (RUO)
AcroMetrix Multi-Analyte SARS-CoV-2, Flu A/B, RSV A/B Control (RUO)
MAS SARS-CoV-2 Serology Quality Controls
Validate and monitor performance of COVID-19 tests with this full length genomic RNA from SARS-COV-2 in a proprietary buffer.
Verify daily runs and validate lot-to-lot performance with a this full-process qualitative control.
Confirm five targets with this whole pathogen control containing the entire viral genome.
Obtain an unbiased assessment of your serological assays with MAS SARS-CoV-2 positive and negative controls.
- Full-length genomic RNA
- Low-positive and ultra-low-positive concentrations
- In-process QC to reduce extraction costs
- Validated open vial and freeze / thaw stability to maximize use and reduce waste
- Inactivated SARS-CoV-2
- Mimics human specimen
- Full process QC – Compatible with both manual and automated workflows
- Validated open vial and freeze / thaw stability to maximize use and reduce waste
- Contains 5 inactivated viruses in one vial
- SARS-CoV-2
- Influenza A
- Influenza B
- Respiratory Syncytial Virus (RSV) A
- Respiratory Syncytial Virus (RSV) B
- Mimics clinical sample/ full process control
- Only combo control in the market to include both RSV A and B with SARS-CoV-2
- Quantitative control compatible with most of the assays in the market
- The MAS SARS-CoV-2 IgG Positive Control
- Detects IgG antibodies for monitoring of SARS-CoV-2
- The MAS SARS-CoV-2 Negative Control is
- Non-reactive or negative for the detection of SARS-CoV-2
- Standalone Controls for SARS-CoV-2 virus
- Platform agnostic – True Third-party quality controls
- Can be used across multiple laboratory instruments - Not optimized against single assay
- Reduces time, optimizes workflow, increases productivity and minimizes scrap
- Ready to use
- Excellent OVS- minimizes waste
- Manufactured to mimic patient samples
- Regulatory status: CE-IVD